Press Releases

CytoSMART Technologies Introduces Machine-Learning Algorithm for Organoid Analysis on the CytoSMART Omni Systems

CytoSMART Technologies announced the launch of a new Organoid Analysis Module for use with its flagship CytoSMART Omni live-cell imaging product line.

Calyx Named Medical Imaging Provider by Clinscience

Clinscience extends Calyx’s reliable, expedited imaging services to its global pharmaceutical customers

mdgroup recognised as one of the UK's fastest-growing private companies

mdgroup recognised as one of the UK's fastest-growing private companies 9 June 2022 - Bracknell, UK: mdgroup has been shortlisted as one of the UK's fastest-growing private companies in the inaugural Sunday Times 100 ranking.

CordenPharma Increases xRNA-based Capabilities with a Strategic Investment in LNP Formulation Services at its Caponago Injectable Facility

CordenPharma, a full-service Contract Development Manufacturing Organization (CDMO) of Active Pharmaceutical Ingredients (APIs), Excipients, Drug Products & Packaging services, has increased its xRNA capabilities at its sterile injectable facility in Caponago, Italy.

Terumo Pharmaceutical Solutions offers pre-fillable syringe solutions for demanding low dose applications such as ophthalmic

Terumo Pharmaceutical Solutions (TPS), a division of Terumo Corporation (TSE: 4543) and a leading manufacturer of injection, primary container, and infusion therapy devices, has launched a pre-fillable polymer syringe for low dose applications such as ophthalmic drugs.

ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions Announce a New Antibody Cocktail Effective Against Major Variants of SARS-CoV-2

ProteoGenix, Aseem Healthcare, and Trident Biopharm Solutions are pleased to announce the development of a new antibody cocktail effective against major variants of SARS-CoV-2.

Veeva Announces Clinical Study Training Application

Veeva Systems announces new application, Veeva Vault Study Training, for integrated and automated clinical training.

Abzena Selects IPS for Turnkey Delivery of New CGMP Facility in North Carolina

IPS to provide full design, construction management and CQV services for Abzena's new monoclonal antibody (mAb) facility in Sanford, North Carolina

Dolomite Bio releases hydrogel reagent kits for agarose encapsulation and 3D cell culture research

Dolomite Bio launches new hydrogel focused reagent kits, enabling high-throughput encapsulation of cells in hydrogel scaffolds.

Diurnal to present research into new treatments of Congenital Adrenal Hyperplasia (CAH) at ENDO 2022

Diurnal Group plc (AIM: DNL), will be presenting research findings on the treatment and management of congenital adrenal hyperplasia (CAH) at this year’s American Endocrine Society meeting, ENDO 2022, which will be taking place between 11-14 June 2022 in Atlanta, USA.

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value

DFE Pharma Appoints New Global HR Director to Further Invest in Team and Add Value Goch, Germany (June 7th 2022) – DFE Pharma, a global leader in pharma-, biopharma-and nutraceutical excipient solutions, has appointed Marie-Louise Mans as Global Human Resources (HR) Director, joining as a member of the Leadership Team. DFE Pharma, headquartered in Goch, Germany, has facilities in 9 countries, employing around 450 people globally.

Antibody-drug Conjugates Manufacturing and Future Focus

ADCs demonstrated great potential for the treatment of cancers, and simultaneously require unique supporting infrastructure to meet biopharmaceutical industry standards for safe, effective, and reliable manufacturing.

Full-Scale Mitochondrial Bioenergetics Services at Creative Biogene

Creative Biogene provides partners with comprehensive range of mitochondrial bioenergetics detection and analysis services based on years of experience and high-end instruments.

Optimal Peptides of BOC Sciences Arouse Heated Discussions at TIDES USA 2022

A New Phase of BOC Sciences Partnership Expansion Unlocked after TIDES USA 2022

BOC Sciences Grandly Promotes: One-Stop CDMO Service Platform for Drug Development 

BOC Sciences recently initiated an unprecedentedly comprehensive CDMO service platform to accelerate technology transfer of medicines from research to commercial scale.

Huateng Pharma has the capability to rapidly produce key intermediates for antiviral drugs

Huateng Pharma has the capabilities to perform process development and scale-up antiviral drug intermediates, eg. paxlovid intermediates.

Biopharma PEG Supports mRNA Vaccine Delivery with The Production of PEG Derivatives for LNP System

Biopharma PEG provides lab and GMP grade PEG lipids for the LNP systems in mRNA vaccines.

CD Formulation Launches API Chemical Modification Services to Address Drug Solubility, Bioavailability, and Dissolution Rate Issues

Having abundant expertise in drug formulation and pharmaceutical preparation, the New York-based CRO company CD Formulation recently announces that it is now capable of conducting a wide range of API chemical modification services, including pH modification drug molecular service, drug salt formation service, drug pegylation service, and different groups of precursor drug design service, to help researchers address some of the long-standing issues in drug development like drug solubility, bioavailability, and dissolution rate.

BOC Sciences: A Robust Isotope Labeling Service Vendor

BOC Sciences offers professional stable isotope labeling services to support worldwide partners from preclinical to commercial stages.